Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.

Direct comparison of the hepatoma cell lines HepG2 and HepaRG has previously been performed by only evaluating a limited set of genes or proteins. In this study, we examined the whole-genome gene expression of both cell lines before and after exposure to the genotoxic (GTX) carcinogens aflatoxin B1 and benzo[a]pyrene and the nongenotoxic (NGTX) carcinogens cyclosporin A, 17beta-estradiol, and 2,3,7,8-tetrachlorodibenzo-para-dioxin for 12 and 48 h. Before exposure, this analysis revealed an extensive network of genes and pathways, which were regulated differentially for each cell line. The comparison of the basal gene expression between HepG2, HepaRG, primary human hepatocytes (PHH), and liver clearly showed that HepaRG resembles PHH and liver the most. After exposure to the GTX and NGTX carcinogens, for both cell lines, common pathways were found that are important in carcinogenesis, for example, cell cycle regulation and apoptosis. However, also clear differences between exposed HepG2 and HepaRG were observed, and these are related to common metabolic processes, immune response, and transcription processes. Furthermore, HepG2 performs better in discriminating between GTX and NGTX carcinogens. In conclusion, these results have shown that HepaRG is a more suited in vitro liver model for biological interpretations of the effects of exposure to chemicals, whereas HepG2 is a more promising in vitro liver model for classification studies using the toxicogenomics approach. Although, it should be noted that only five carcinogens were used in this study.

[1]  G Williamson,et al.  Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. , 1998, Mutation research.

[2]  Y. Wong,et al.  Molecular mechanisms mediating the G protein-coupled receptor regulation of cell cycle progression , 2007, Journal of molecular signaling.

[3]  S. Strom,et al.  Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. , 2007, Toxicology and applied pharmacology.

[4]  N. Javitt,et al.  Bile acid synthesis in HepG2 cells: effect of cyclosporin. , 1994, Journal of lipid research.

[5]  Frank Stahl,et al.  Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[6]  M. Makishima,et al.  Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene. , 2008, Toxicology and applied pharmacology.

[7]  Weida Tong,et al.  ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research. , 2003, Environmental health perspectives.

[8]  J. Kleinjans,et al.  Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. , 2005, Mutation research.

[9]  H. Gelboin.  Benzo[alpha]pyrene metabolism, activation and carcinogenesis: role and regulation of mixed-function oxidases and related enzymes. , 1980, Physiological reviews.

[10]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[11]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[13]  Stacy L. Gelhaus,et al.  Metabolism of benzo[a]pyrene in human bronchoalveolar H358 cells using liquid chromatography-mass spectrometry. , 2007, Chemical research in toxicology.

[14]  A. Guillouzo,et al.  Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. , 2009, Toxicology and applied pharmacology.

[15]  R. Dunn,et al.  Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  P. Watkins.  The role of cytochromes P-450 in cyclosporine metabolism. , 1990, Journal of the American Academy of Dermatology.

[17]  Weida Tong,et al.  Development of public toxicogenomics software for microarray data management and analysis. , 2004, Mutation research.

[18]  R. Metcalf,et al.  p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines. , 1993, Carcinogenesis.

[19]  Tommy B Andersson,et al.  Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies , 2008, Drug Metabolism and Disposition.

[20]  André Guillouzo,et al.  The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics. , 2007, Chemico-biological interactions.

[21]  W. Schoonen,et al.  Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[22]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[23]  M. Nakajima,et al.  Cytochrome P450-mediated Metabolism of Estrogens and Its Regulation in Human , 2004 .

[24]  J. Kleinjans,et al.  Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. , 2004, Carcinogenesis.

[25]  A. Guillouzo,et al.  Functional expression, inhibition and induction of CYP enzymes in HepaRG cells. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[26]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[27]  W. F. Greenlee,et al.  Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. , 2001, Annual review of pharmacology and toxicology.

[28]  U. Müller,et al.  Discriminating two classes of toxicants through expression analysis of HepG2 cells with DNA arrays. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[29]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[30]  U. Brunk,et al.  Modulation of metabolism in HepG2 cells upon treatment with cyclosporin A and Nva2-cyclosporin. , 1991, Experimental and molecular pathology.

[31]  Angela J Harris,et al.  Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. , 2004, Mutation research.

[32]  I. Giddings,et al.  Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2 , 2006, BMC Genomics.

[33]  C. Wolf,et al.  Purification and characterization of an anticonvulsant-induced human cytochrome P-450 catalysing cyclosporin metabolism. , 1989, The Biochemical journal.

[34]  J. Brockmöller,et al.  Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. , 2006, Chemical research in toxicology.

[35]  J. Waring,et al.  Trovafloxacin-Induced Gene Expression Changes in Liver-Derived in Vitro Systems: Comparison of Primary Human Hepatocytes to HepG2 Cellss⃞ , 2008, Drug Metabolism and Disposition.

[36]  C. Mayer,et al.  NuGO contributions to GenePattern , 2008, Genes & Nutrition.

[37]  G. Siest,et al.  Compared effect of immunosuppressive drugs cyclosporine A and rapamycin on cholesterol homeostasis key enzymes CYP27A1 and HMG-CoA reductase. , 2007, Basic & clinical pharmacology & toxicology.

[38]  D. Acosta,et al.  Predictive value of in vitro model systems in toxicology. , 1998, Annual review of pharmacology and toxicology.

[39]  C. Duggan,et al.  The use of genomics technology to investigate gene expression changes in cultured human liver cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[40]  Tommy B. Andersson,et al.  HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans , 2008, Drug Metabolism And Disposition.